Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Novelion Therapeutics Inc (NVLNF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Novelion Therapeutics historical data, for real-time data please try another search
0.702 0.000    0.00%
04/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.700 - 0.750
Novelion Therapeutics 0.702 0.000 0.00%

NVLNF Balance Sheet

 
Featured here, the Balance Sheet for Novelion Therapeutics Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2019
31/03
2018
31/12
2018
30/09
2018
30/06
Total Current Assets 106.22 102.54 83.26 86.34
Cash and Short Term Investments 51.92 45.15 27.38 39.98
Cash - - - -
Cash & Equivalents 51.92 45.15 27.38 39.98
Short Term Investments - - - -
Total Receivables, Net 26.88 28.91 21.56 18.36
Accounts Receivables - Trade, Net 26.88 28.91 21.56 18.36
Total Inventory 13.41 12.74 19.12 13.24
Prepaid Expenses 14.02 15.73 15.2 14.76
Other Current Assets, Total - - - -
Total Assets 342.12 341.71 324.99 340.33
Property/Plant/Equipment, Total - Net 2.51 1.58 1.97 2.38
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 193.9 200.18 206.45 212.72
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 39.49 37.41 33.31 38.89
Other Assets, Total - - - -
Total Current Liabilities 443.46 410.39 370.86 64.9
Accounts Payable 6.17 6.01 13.45 10.55
Payable/Accrued - - - -
Accrued Expenses 53.67 55.88 54.01 54.34
Notes Payable/Short Term Debt 73.93 73.68 16.37 -
Current Port. of LT Debt/Capital Leases 285.52 274.81 287.03 -
Other Current liabilities, Total 24.17 - 16.37 -
Total Liabilities 461.07 430.57 394.17 385.29
Total Long Term Debt - - - 292.93
Long Term Debt - - - 292.93
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 17.61 20.19 23.31 27.46
Total Equity -118.95 -88.86 -69.19 -44.96
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 552.51 552.51 552.51 552.51
Additional Paid-In Capital 79.93 79.3 78.75 78.14
Retained Earnings (Accumulated Deficit) -854.15 -822.3 -802.87 -778.06
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 102.76 101.64 102.43 102.46
Total Liabilities & Shareholders' Equity 342.12 341.71 324.99 340.33
Total Common Shares Outstanding 19.04 19.02 18.86 18.85
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NVLNF Comments

Write your thoughts about Novelion Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email